gvtcx

Investigational Medicinial Product (IMP) - IM Woman Trial

London School of Hygiene & Tropical Medicine Published 21 Aug 2023 Contracts Finder

key details

Value£1,067,000
Statuscomplete
Category (CPV) 33141310 +8 more
RegionLondon
Deadline5 Jan 2022
Contract start1 Aug 2023
Contract end31 Aug 2025
Procedureopen
SME suitableYes
OCIDocds-b5fd17-5d20a6df-308a-46fa-beca-e486f33eeffa

Award

SupplierValueDateStatus
Sharp Clinical Services (UK) Ltd £1,066,444 9 Aug 2023 active

description

Manufacturing and packing of IMP for the IM Woman Trial due to commence in March 2023.

A randomised, triple-blind, three-arm, non-inferiority trial to assess the efficacy and safety of intramuscular tranexamic acid compared to intravenous tranexamic acid and placebo in women having vvaginal and caesarean section births.

Three arms include experimental treatment (IM TXA), reference treatment/active control (IV TXA), and placebo control (0.9% sodium chloride solution).

Provision of treatment kit boxes required for 4 campaigns with approximately 10,000 patient packs per campaign. Recruitment period is 24 months - campaign approximately once every 6 months commencing March 2023.

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
22 Nov 2021 Tender (tender) · d9d3f59a-3177-4b49-b2a1-9ac58d74771f-487848
21 Aug 2023 Award (award) · 64f128db-8318-4633-9c60-3f438402ca2a-673857

more from London School of Hygiene & Tropical Medicine

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.